GS1 New drug discovery pathway based on proteomics and structural information   GS1-1. Structural biology of transcriptional regulation mechanisms by the Ets transcription factor family   GS1-2. Development of artificial enzymes based on the myoglobin scaffold   GS1-3. Structural basis of the collagen-binding mode of discoidin domain receptor 2   GS1-4. Establishment of antibody proteomics for identification of disease-related proteins and high-throughput isolation of monoclonal antibodies   GS1-5. Drug discovery for amyotrophic lateral sclerosis based on proteome informations: intracellular copper distribution is potential drug target   GS1-6. Development of a high-throughput system for creation of functional mutant proteins useful for pharmaceutical proteomics